Christian Vasquez - 09 Feb 2023 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Vice President of Finance, Corporate Controller and Secretary
Signature
/s/ Christian Vasquez
Issuer symbol
BCAB
Transactions as of
09 Feb 2023
Net transactions value
-$682
Form type
4
Filing time
01 Mar 2023, 17:31:20 UTC
Previous filing
02 Feb 2023
Next filing
29 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCAB Common Stock Tax liability $682 -229 -0.28% $2.98 82,709 28 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCAB Employee Stock Option (right to buy) Award $0 +135,000 $0.000000 135,000 09 Feb 2023 Common Stock 135,000 $3.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
F2 The option vests over a period of four years, with 25% of the shares underlying the option vesting on the first anniversary of the date of grant, and the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service to the company through the applicable vesting dates.

Remarks:

Vice President of Finance, Corporate Controller and Secretary